Showing results (2171-2180 of 2,629) with videos related to

Sort By:
Pageof 263
Chemistry & Biology|January 1, 2004
Designer gene therapy using an Escherichia coli purine nucleoside phosphorylase/prodrug systemEric M Bennett, Ruchi Anand, Paula W Allan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2012
A multicenter phase I trial of PX-866, an oral irreversible phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumorsDavid S Hong, Daniel W Bowles, Gerald S Falchook, et al.
Cancer|June 19, 2025
First-in-human phase 1 study of KHK2455 monotherapy and in combination with mogamulizumab in patients with advanced solid tumorsTimothy A Yap, Olivier Rixe, Capucine Baldini, et al.
Oncotarget|February 9, 2013
Targeted therapy of advanced gallbladder cancer and cholangiocarcinoma with aggressive biology: eliciting early response signals from phase 1 trialsIshwaria M Subbiah, Vivek Subbiah, Apostolia M Tsimberidou, et al.
Histopathology|February 8, 2020
Pancreatic ductal adenocarcinoma: tumour regression grading following neoadjuvant FOLFIRINOX and radiationAzfar Neyaz, Elisabeth S Tabb, Angela Shih, et al.
Biorxiv : the Preprint Server for Biology|March 17, 2025
Inhibitors of oncogenic Kras specifically prime CTLA4 blockade to transcriptionally reprogram Tregs and overcome resistance to suppress pancreas cancerKrishnan K Mahadevan, Ana S Maldonado, Bingrui Li, et al.
Research Square|April 8, 2024
Androgen loss weakens anti-tumor immunity and accelerates brain tumor growthJuyeun Lee, Yoon-Mi Chung, Lee Curtin, et al.
Cancer Journal (Sudbury, Mass.)|January 22, 2025
Severe Lymphopenia Predicts Poorer Survival in Patients With Rectal Cancer Undergoing Neoadjuvant ChemoradiationDaniel W Kim, Grace Lee, Elise M Cai, et al.
ESMO Open|June 2, 2022
Quality of life with encorafenib plus cetuximab with or without binimetinib treatment in patients with BRAF V600E-mutant metastatic colorectal cancer: patient-reported outcomes from BEACON CRCS Kopetz, A Grothey, E Van Cutsem, et al.
Frontiers in Immunology|August 19, 2022
Utomilumab in Patients With Immune Checkpoint Inhibitor-Refractory Melanoma and Non-Small-Cell Lung CancerDavid S Hong, Ajay K Gopal, Alexander N Shoushtari, et al.
Pageof 263